You could be reading the full-text of this article now if you...

If you have access to this article through your institution,
you can view this article in

The early response of the postmenopausal endometrium to tamoxifen: expression of estrogen receptors, progesterone receptors, and Ki-67 antigen

Tregón, María-Luisa MD1; Blümel, Juan-Enrique MD2; Tarín, Juan J. PhD3; Cano, Antonio MD1

Menopause:
Articles
Abstract

Objective: To enlighten the early response of endometrium to tamoxifen by assessing the expression of estrogen receptors, progesterone receptors, Ki-67, and the histological response in endometria from normal postmenopausal women treated for 21 days with tamoxifen.

Design: A total of 40 women, scheduled to undergo vaginal hysterectomy because of uterine prolapse, were randomly assigned to the tamoxifen group (20 mg/day; 20 women) or the control group (20 women). Samples were obtained from the upper and the lower thirds of the uterine cavity. Standard immunohistochemical staining of estrogen and progesterone receptors and of Ki-67 was performed on frozen sections. Staining was assessed using semiquantitative immunoreactivity scores.

Results: Simple endometrial hyperplasia was diagnosed in 18 of the 20 samples exposed to tamoxifen compared with only 2 of the 20 controls (P < 0.0005). Staining was increased in both the epithelium and stroma in the tamoxifen samples, a difference that was significant for estrogen receptors in glandular epithelium (180 ± 80 v 110 ± 110;P < 0.05). Also, Ki-67 antigen was expressed more frequently in both glandular epithelium (P < 0.05) and stroma (P < 0.05) in the tamoxifen samples.

Conclusions: Tamoxifen rapidly up-regulated the cell proliferation markers, an effect that was associated with enhanced growth as confirmed by increased expression of estrogen receptors and Ki-67, in addition to a high incidence of glandular hyperplasia.

Author Information

From the 1Department of Pediatrics, Obstetrics and Gynecology, Facultad de Medicina, Universidad de Valencia, Valencia, Spain, the 2Climacteric Unit, Barros Luco-Tradeau Hospital, Santiago, Chile, and the 3Department of Functional Biology and Physical Anthropology, Facultad de Ciencias Biológicas, Universidad de Valencia, Valencia, Spain.

Received April 24, 2002; revised and accepted August 27, 2002.

This work was supported by grants 1FD97-1035-C02-01 from the Comisión Interministerial de Ciencia y Tecnología, Madrid, Spain, and the European Union, 00/0960 from Fondo de Investigación Sanitaria, Madrid, Spain, and GV99-6-1-04 from the Consellería de Cultura, Educació i Ciència, Generalitat Valenciana, Valencia, Spain.

Address correspondence to Antonio Cano, MD, Department of Pediatrics, Obstetrics and Gynecology, Facultad de Medicina, Av. Blasco Ibáñez 17, E-46010 Valencia, Spain. E-mail: acano@uv.es.

©2003The North American Menopause Society